ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01606579
Recruitment Status : Completed
First Posted : May 25, 2012
Last Update Posted : August 17, 2017
Sponsor:
Collaborator:
inVentiv Health Clinical
Information provided by (Responsible Party):
Prism Pharma Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 30, 2016
  Actual Study Completion Date : December 30, 2016